Health & Safety

Latest Content

A matter of scale

Funding support and infrastructure are needed to bring bio-based products and processes to market and meet net zero targets, urges Lynsey Dunbar. Otherwise, start-ups will be looking elsewhere.

In Depth

Achieving an animal free IHC

With alternative technologies available, we should be seeking antibody alternatives that avoid the unnecessary use of animals in research, urges Dr David Bunka.

Comment And Analysis

A matter of scale

Funding support and infrastructure are needed to bring bio-based products and processes to market and meet net zero targets, urges Lynsey Dunbar. Otherwise, start-ups will be looking elsewhere.

Interviews

Floored science

The lab is a key and growing component of the annual CHEMUK Expo. Managing director of show organisers UK Industry Events, Ian Stone discusses how he seeks to balance laboratory R&D with scaled-up ma…